Aredia and Zometa Verdict

Novartis Pharmaceuticals Corp. is on the hook for nearly $1.2 million in damages after a federal jury in North Carolina found that the company failed to warn a woman's doctor that its Aredia and Zometa drugs could cause a disfiguring bone condition. The actual verdict was $12.8 million but is being reduced to $1.2 million due to North Carolina tort reform laws.

The woman's family’s lawsuit was the third product-liability case to go to trial over the bone-strengthening treatments. Last month, a New Jersey jury rejected a woman’s claims that Aredia and Zometa caused her jaw deterioration. In October 2009, a Montana jury ordered Novartis to pay $3.2 million in damages to a cancer patient who made the same claims over the medicines.

Novartis is facing about 700 suits over the bone-strengthening medicines, according to court filings. Some of the cases have been consolidated before a federal judge in Tennessee. Others have been sent back to their home courts for trial. Still other cases have been heard in state courts around the country.

Our Zometa/Aredia cases are currently still consolidated in the MDL awaiting transfer for trial.


Popular posts from this blog

Safety for Your Family or Corporations?

New Report on Nursing Home Negligence

Supreme Court Knocks Down FDA Preemption